Clinical Trial Update: plasmApuane CoV-2 : Efficacy and Safety of Immune Covid-19 Plasma in Covid-19 Pneumonia in Non ITU Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy and safety of Immune Covid-19 Plasma for COVID-19 pneumonia in non-ICU patients is underway; current status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Pneumonia

Drugs mentioned

• plasmApuane CoV-2

Snippet

Sponsor: Azienda USL Toscana Nord Ovest | Conditions: Covid-19 Pneumonia | Phase 2 | Status: UNKNOWN